US Stock MarketDetailed Quotes

ADILW Adial Pharmaceuticals Inc C/ Wts 31/07/2023 (To Pur Com)

Watchlist
  • 0.0009
  • 0.00000.00%
Trading Jul 28 09:30 ET
0Market Cap0.00P/E (TTM)

Adial Pharmaceuticals Inc C/ Wts 31/07/2023 (To Pur Com) Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
(Q2)Jun 30, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
7.93%-2.3M
6.39%-11.19M
26.22%-1.75M
3.56%-3.4M
-10.33%-3.53M
12.19%-2.5M
-56.55%-11.95M
9.22%-2.37M
-59.82%-3.53M
-225.15%-3.2M
Net income from continuing operations
0.07%-2.91M
34.45%-12.73M
50.84%-2.87M
27.99%-3.11M
13.36%-3.85M
39.84%-2.91M
-78.31%-19.42M
-68.07%-5.83M
-29.44%-4.32M
-145.21%-4.44M
Operating gains losses
----
----
----
----
----
----
---22.13K
--0
--0
---29.09K
Depreciation and amortization
7.68%15.84K
9.79%60.5K
-5.15%15.55K
24.28%15.26K
7.24%14.98K
18.01%14.71K
9,670.57%55.11K
11,524.11%16.39K
8,609.22%12.28K
9,807.80%13.97K
Deferred tax
----
99.47%-502
----
----
----
----
---94.08K
----
----
----
Other non cash items
109.59%14K
-285.29%-522K
-501.70%-325K
-127.32%-75K
-64.43%24K
-2,226.69%-146K
--281.71K
---54.01K
--274.52K
--67.48K
Change In working capital
126.65%117.61K
-193.35%-1.37M
-40.25%691.64K
-15.18%-791.9K
-341.43%-825.56K
-167.62%-441.24K
17.63%1.46M
138.72%1.16M
-253.07%-687.54K
-20.54%341.95K
-Change in prepaid assets
2.01%126.09K
-212.95%-378.71K
-40.26%242.46K
44.12%-237.62K
-428.72%-507.16K
-38.30%123.6K
107.37%335.29K
459.74%405.89K
-1,217.24%-425.21K
11.57%154.28K
-Change in payables and accrued expense
100.92%5.1K
-180.48%-938.77K
-39.43%462.05K
-110.68%-541.69K
-254.37%-306.1K
-219.56%-553.03K
7.68%1.17M
84.97%762.78K
-162.54%-257.11K
-32.11%198.29K
-Change in other current liabilities
-14.96%-13.58K
-32.80%-49.59K
-15.90%-12.87K
-141.21%-12.59K
-15.89%-12.31K
-13.71%-11.81K
---37.34K
---11.11K
---5.22K
---10.62K
Cash from discontinued investing activities
Operating cash flow
7.93%-2.3M
6.39%-11.19M
26.22%-1.75M
3.56%-3.4M
-10.33%-3.53M
12.19%-2.5M
-56.55%-11.95M
9.22%-2.37M
-59.82%-3.53M
-225.15%-3.2M
Investing cash flow
Cash flow from continuing investing activities
0
0
0
90.28%-34.02K
0
0
-33.73K
Net PPE purchase and sale
----
--0
--0
--0
----
----
---64.61K
--0
--0
---33.73K
Net business purchase and sale
----
--0
--0
--0
----
----
--30.59K
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
----
--0
--0
--0
----
----
90.28%-34.02K
--0
--0
---33.73K
Financing cash flow
Cash flow from continuing financing activities
-93.32%609.61K
-33.12%9.13M
0
0
-99.93%1.87K
123.59%9.12M
143.34%13.64M
1.25M
478.94%5.5M
-39.68%2.81M
Net common stock issuance
-93.32%609.61K
-22.35%9.12M
--0
--0
--0
245.46%9.12M
127.84%11.75M
--800K
1,000.00%5.5M
-39.68%2.81M
Proceeds from stock option exercised by employees
----
-99.90%1.87K
--0
--0
----
----
320.99%1.89M
--455K
--0
--0
Cash from discontinued financing activities
Financing cash flow
-93.32%609.61K
-33.12%9.13M
--0
--0
-99.93%1.87K
123.59%9.12M
143.34%13.64M
--1.25M
478.94%5.5M
-39.68%2.81M
Net cash flow
Beginning cash position
-33.99%4M
37.74%6.06M
-19.88%5.75M
75.76%9.16M
125.07%12.69M
37.74%6.06M
-35.06%4.4M
-2.51%7.18M
-39.59%5.21M
13.86%5.64M
Current changes in cash
-125.49%-1.69M
-224.04%-2.06M
-56.60%-1.75M
-272.76%-3.4M
-725.24%-3.53M
435.82%6.63M
169.91%1.66M
62.28%-1.12M
256.56%1.97M
-111.66%-428.06K
End cash Position
-81.78%2.31M
-33.99%4M
-33.99%4M
-19.88%5.75M
75.76%9.16M
125.07%12.69M
37.74%6.06M
37.74%6.06M
-2.51%7.18M
-39.59%5.21M
Free cash flow
7.93%-2.3M
6.89%-11.19M
26.22%-1.75M
3.56%-3.4M
-9.19%-3.53M
13.14%-2.5M
-57.39%-12.01M
9.22%-2.37M
-59.82%-3.53M
-228.58%-3.24M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021(Q2)Jun 30, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 7.93%-2.3M6.39%-11.19M26.22%-1.75M3.56%-3.4M-10.33%-3.53M12.19%-2.5M-56.55%-11.95M9.22%-2.37M-59.82%-3.53M-225.15%-3.2M
Net income from continuing operations 0.07%-2.91M34.45%-12.73M50.84%-2.87M27.99%-3.11M13.36%-3.85M39.84%-2.91M-78.31%-19.42M-68.07%-5.83M-29.44%-4.32M-145.21%-4.44M
Operating gains losses ---------------------------22.13K--0--0---29.09K
Depreciation and amortization 7.68%15.84K9.79%60.5K-5.15%15.55K24.28%15.26K7.24%14.98K18.01%14.71K9,670.57%55.11K11,524.11%16.39K8,609.22%12.28K9,807.80%13.97K
Deferred tax ----99.47%-502-------------------94.08K------------
Other non cash items 109.59%14K-285.29%-522K-501.70%-325K-127.32%-75K-64.43%24K-2,226.69%-146K--281.71K---54.01K--274.52K--67.48K
Change In working capital 126.65%117.61K-193.35%-1.37M-40.25%691.64K-15.18%-791.9K-341.43%-825.56K-167.62%-441.24K17.63%1.46M138.72%1.16M-253.07%-687.54K-20.54%341.95K
-Change in prepaid assets 2.01%126.09K-212.95%-378.71K-40.26%242.46K44.12%-237.62K-428.72%-507.16K-38.30%123.6K107.37%335.29K459.74%405.89K-1,217.24%-425.21K11.57%154.28K
-Change in payables and accrued expense 100.92%5.1K-180.48%-938.77K-39.43%462.05K-110.68%-541.69K-254.37%-306.1K-219.56%-553.03K7.68%1.17M84.97%762.78K-162.54%-257.11K-32.11%198.29K
-Change in other current liabilities -14.96%-13.58K-32.80%-49.59K-15.90%-12.87K-141.21%-12.59K-15.89%-12.31K-13.71%-11.81K---37.34K---11.11K---5.22K---10.62K
Cash from discontinued investing activities
Operating cash flow 7.93%-2.3M6.39%-11.19M26.22%-1.75M3.56%-3.4M-10.33%-3.53M12.19%-2.5M-56.55%-11.95M9.22%-2.37M-59.82%-3.53M-225.15%-3.2M
Investing cash flow
Cash flow from continuing investing activities 00090.28%-34.02K00-33.73K
Net PPE purchase and sale ------0--0--0-----------64.61K--0--0---33.73K
Net business purchase and sale ------0--0--0----------30.59K--0--0--0
Cash from discontinued investing activities
Investing cash flow ------0--0--0--------90.28%-34.02K--0--0---33.73K
Financing cash flow
Cash flow from continuing financing activities -93.32%609.61K-33.12%9.13M00-99.93%1.87K123.59%9.12M143.34%13.64M1.25M478.94%5.5M-39.68%2.81M
Net common stock issuance -93.32%609.61K-22.35%9.12M--0--0--0245.46%9.12M127.84%11.75M--800K1,000.00%5.5M-39.68%2.81M
Proceeds from stock option exercised by employees -----99.90%1.87K--0--0--------320.99%1.89M--455K--0--0
Cash from discontinued financing activities
Financing cash flow -93.32%609.61K-33.12%9.13M--0--0-99.93%1.87K123.59%9.12M143.34%13.64M--1.25M478.94%5.5M-39.68%2.81M
Net cash flow
Beginning cash position -33.99%4M37.74%6.06M-19.88%5.75M75.76%9.16M125.07%12.69M37.74%6.06M-35.06%4.4M-2.51%7.18M-39.59%5.21M13.86%5.64M
Current changes in cash -125.49%-1.69M-224.04%-2.06M-56.60%-1.75M-272.76%-3.4M-725.24%-3.53M435.82%6.63M169.91%1.66M62.28%-1.12M256.56%1.97M-111.66%-428.06K
End cash Position -81.78%2.31M-33.99%4M-33.99%4M-19.88%5.75M75.76%9.16M125.07%12.69M37.74%6.06M37.74%6.06M-2.51%7.18M-39.59%5.21M
Free cash flow 7.93%-2.3M6.89%-11.19M26.22%-1.75M3.56%-3.4M-9.19%-3.53M13.14%-2.5M-57.39%-12.01M9.22%-2.37M-59.82%-3.53M-228.58%-3.24M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data